Literature DB >> 3903026

Influenza virus subtype-specific cytotoxic T lymphocytes lyse target cells coated with a protein produced in E. coli.

A Yamada, J F Young, F A Ennis.   

Abstract

We have tested the ability of the c13 protein, which is a hybrid protein of the first 81 amino acids of the viral nonstructural protein (NS1) and the HA2 subunit of viral hemagglutination produced in E. coli, to render target cells susceptible to the lytic activity of influenza virus-specific cytotoxic T lymphocytes (CTL). The results showed that P815 cells coated with c13 protein were lysed by PR8 virus-induced secondary CTL derived from BALB/c mice. Cold-target inhibition tests clearly demonstrated that c13 protein-coated P815 cells were recognized by an H1 subtype-specific CTL population. Furthermore, PR8 virus-induced CTL derived from C3H mice did not lyse c13 protein-coated P815 cells, suggesting that c13 protein was recognized by CTL in conjunction with H-2d products. These findings suggest that this protein interacts with the cellular plasma membrane and makes target cells recognizable by H-2-restricted, influenza virus subtype-specific CTL.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3903026      PMCID: PMC2187928          DOI: 10.1084/jem.162.5.1720

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

1.  Fusion of Sendai virus with the target cell membrane is required for T cell cytotoxicity.

Authors:  M Gething; U Koszinowski; M Waterfield
Journal:  Nature       Date:  1978-08-17       Impact factor: 49.962

2.  Immunologic recognition of influenza virus-infected cells. I. Generation of a virus-strain specific and a cross-reactive subpopulation of cytotoxic T cells in the response to type A influenza viruses of different subtypes.

Authors:  T J Braciale
Journal:  Cell Immunol       Date:  1977-10       Impact factor: 4.868

3.  Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Nature       Date:  1974-04-19       Impact factor: 49.962

4.  Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells.

Authors:  A R Townsend; A J McMichael; N P Carter; J A Huddleston; G G Brownlee
Journal:  Cell       Date:  1984-11       Impact factor: 41.582

5.  Processing of lysozyme by macrophages: identification of the determinant recognized by two T-cell hybridomas.

Authors:  P M Allen; D J Strydom; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

6.  Integration of a virus membrane protein into the lipid bilayer of target cells as a prerequisite for immune cytolysis. Specific cytolysis after virosome-target cell fusion.

Authors:  B Morein; D Barz; U Koszinowski; V Schirrmacher
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

7.  Cytotoxic T lymphocyte recognition of the influenza hemagglutinin gene product expressed by DNA-mediated gene transfer.

Authors:  T J Braciale; V L Braciale; T J Henkel; J Sambrook; M J Gething
Journal:  J Exp Med       Date:  1984-02-01       Impact factor: 14.307

8.  Cytotoxic T-cell responses in mice infected with influenza and vaccinia viruses vary in magnitude with H-2 genotype.

Authors:  P C Doherty; W E Biddison; J R Bennink; B B Knowles
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

9.  Most influenza A virus-specific memory cytotoxic T lymphocytes react with antigenic epitopes associated with internal virus determinants.

Authors:  U Kees; P H Krammer
Journal:  J Exp Med       Date:  1984-02-01       Impact factor: 14.307

10.  Influenza virus hemagglutinin-specific cytotoxic T cell response induced by polypeptide produced in Escherichia coli.

Authors:  A Yamada; M R Ziese; J F Young; Y K Yamada; F A Ennis
Journal:  J Exp Med       Date:  1985-08-01       Impact factor: 14.307

View more
  11 in total

1.  Discordance between antibody and T cell responses in recipients of trivalent inactivated influenza vaccine.

Authors:  Mary Dawn T Co; Laura Orphin; John Cruz; Pamela Pazoles; Alan L Rothman; Francis A Ennis; Masanori Terajima
Journal:  Vaccine       Date:  2008-02-26       Impact factor: 3.641

Review 2.  Recognition of influenza virus proteins by cytotoxic T lymphocytes.

Authors:  A R Townsend
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

3.  Immunological aspects of the prevention of viral diseases. WHO Workshop.

Authors: 
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

4.  GM-CSF in the lung protects against lethal influenza infection.

Authors:  Fang-Fang Huang; Peter F Barnes; Yan Feng; Ruben Donis; Zissis C Chroneos; Steven Idell; Timothy Allen; Daniel R Perez; Jeffrey A Whitsett; Kyri Dunussi-Joannopoulos; Homayoun Shams
Journal:  Am J Respir Crit Care Med       Date:  2011-04-07       Impact factor: 21.405

5.  Dengue virus-specific cross-reactive CD8+ human cytotoxic T lymphocytes.

Authors:  J F Bukowski; I Kurane; C J Lai; M Bray; B Falgout; F A Ennis
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

6.  Anti-influenza virus cytotoxic T lymphocytes recognize the three viral polymerases and a nonstructural protein: responsiveness to individual viral antigens is major histocompatibility complex controlled.

Authors:  J R Bennink; J W Yewdell; G L Smith; B Moss
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

7.  In vitro evidence that commercial influenza vaccines are not similar in their ability to activate human T cell responses.

Authors:  Mary Dawn T Co; Laura Orphin; John Cruz; Pamela Pazoles; Karin M Green; James Potts; Anita M Leporati; Jenny Aurielle B Babon; James E Evans; Francis A Ennis; Masanori Terajima
Journal:  Vaccine       Date:  2008-10-31       Impact factor: 3.641

8.  Active immunization against virus infections due to antigenic drift by induction of crossreactive cytotoxic T lymphocytes.

Authors:  K Kuwano; M Scott; J F Young; F A Ennis
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

9.  Recognition of cloned vesicular stomatitis virus internal and external gene products by cytotoxic T lymphocytes.

Authors:  J W Yewdell; J R Bennink; M Mackett; L Lefrancois; D S Lyles; B Moss
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

10.  Differences in antigen presentation to MHC class I-and class II-restricted influenza virus-specific cytolytic T lymphocyte clones.

Authors:  L A Morrison; A E Lukacher; V L Braciale; D P Fan; T J Braciale
Journal:  J Exp Med       Date:  1986-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.